Because of the COVID-19 pandemic, the last 2 years have been virtual; the organization previously met in Las Vegas in 2019 and 2016.
More than 20,000 professionals from the world of pharmacy return to Las Vegas, Nevada, this weekend for the American Society of Health-System Pharmacists (ASHP) 2022 Midyear Clinical Meeting & Exposition.
Because of the COVID-19 pandemic, the last 2 years have been virtual; the organization previously met in Las Vegas in 2019 and 2016.
Running until Thursday, November 8, the meeting features dozens of topics spanning clinical topics and therapeutics, specialty pharmacy, biosimilars, emergency medicine, infectious diseases, technology, home care, and more.
In addition, many sessions zero in on topics that deal heavily with the day-to-day lives of pharmacists and others working in the current health care climate, such as:
Another track focuses on various topics related to diversity, equity, and inclusion. Sessions encompass supporting those who identify as lesbian, gay, bisexual, transgender, or queer; patients who are disabled; communication strategies for more inclusive work environments; and the dangers of oversimplifying race in clinical practice.
During the meeting, Angela M. Hill, PharmD, CPh, RPh, professor and associate dean of clinical affairs; project director, WE-CARE, University of South Florida Taneja College of Pharmacy, will receive a joint leadership award from ASHP as well as the Association for Black Health-System Pharmacists for her work in addressing health equities.
Another award is being given to Marie A. Chisholm-Burns, PharmD, PhD, MPH, MBA, FCCP, FASHP, FAST, executive vice president and provost at Oregon Health and Science University. She will receive the ASHP Board of Directors’ Distinguished Leadership Award for her work in pharmacy practice leadership and academic pharmacy.
NGS-Based Test Accurately Detects Post–Allo-HSCT Relapse in AML, MDS
February 21st 2025The next-generation sequencing (NGS)–based AlloHeme test accurately predicted relapse following allogeneic hematopoietic stem cell transplantation (allo-HSCT) in acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS).
Read More
Insurance Payer Is Associated With Length of Stay After Traumatic Brain Injury
February 21st 2025Among hospitalized patients with traumatic brain injury, Medicaid fee-for-service was associated with longer hospital stays than private insurance and Medicaid managed care organizations.
Read More
NSCLC Advancements Offer Hope, but Disparities Persist
February 20th 2025Ioana Bonta, MD, Georgia Cancer Specialists, discusses the evolving state of non-small cell lung cancer (NSCLC) treatments, their impact on patient outcomes, and the need to address ongoing disparities in these populations.
Read More